Cambridge Investment Research Advisors, Inc. Assertio Holdings, Inc. Call Options Transaction History
Cambridge Investment Research Advisors, Inc.
- $29.4 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ASRT
# of Institutions
109Shares Held
37.1MCall Options Held
755KPut Options Held
39.5K-
Nantahala Capital Management, LLC New Canaan, CT9.27MShares$9.27 Million0.77% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.47MShares$4.47 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.38MShares$2.38 Million0.01% of portfolio
-
Aqr Capital Management LLC Greenwich, CT2.31MShares$2.31 Million0.0% of portfolio
-
Russell Investments Group, Ltd.2.2MShares$2.2 Million0.0% of portfolio
About Assertio Holdings, Inc.
- Ticker ASRT
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 48,178,200
- Market Cap $48.2M
- Description
- Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing sp...